---
title: "Therapeutic Areas — Cardiovascular Clinical Trial Indications | Amavita Research"
url: https://md.amavitaresearch.com/therapeutic-areas
canonical: https://www.amavitaresearch.com/therapeutic-areas
schema_type: WebPage
last_updated: 2026-05-13
---

# Therapeutic Areas

Cardiovascular indications Amavita Research is qualified to run trials in.

- **Heart failure** (HFrEF, HFpEF, iron-deficient HF) — https://www.amavitaresearch.com/therapeutic-areas/heart-failure
- **Hypertension** (uncontrolled, resistant, secondary) — https://www.amavitaresearch.com/therapeutic-areas/hypertension
- **Peripheral artery disease** (claudication, critical limb ischemia, below-the-knee) — https://www.amavitaresearch.com/therapeutic-areas/peripheral-artery-disease
- **Structural heart disease** (TAVR, mitral, tricuspid) — https://www.amavitaresearch.com/therapeutic-areas/structural-heart-disease
- **Acute coronary syndrome** (post-MI, post-PCI optimization) — https://www.amavitaresearch.com/therapeutic-areas/acute-coronary-syndrome
- **Iron deficiency in heart failure** — https://www.amavitaresearch.com/therapeutic-areas/iron-deficiency-in-heart-failure

## Adjacent indications

- Atrial fibrillation (via Dr. Hans C. Rutzen-Lopez, EP)
- Coronary revascularization / high-risk PCI
- Cardiogenic shock (via Dr. William W. O'Neill consultation)
- Pulmonary embolism response

## Key links

- Active trials: https://www.amavitaresearch.com/trials
- Site capabilities: https://www.amavitaresearch.com/capabilities
- Sponsor contact: https://www.amavitaresearch.com/contact-sponsor